0001437749-23-025204.txt : 20230905 0001437749-23-025204.hdr.sgml : 20230905 20230905162818 ACCESSION NUMBER: 0001437749-23-025204 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230831 FILED AS OF DATE: 20230905 DATE AS OF CHANGE: 20230905 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Smith Jason Drew CENTRAL INDEX KEY: 0001821479 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38079 FILM NUMBER: 231236152 MAIL ADDRESS: STREET 1: C/O UROGEN PHARMA LTD. STREET 2: 400 ALEXANDER PARK DRIVE CITY: PRINCETON STATE: NJ ZIP: 08540 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: UroGen Pharma Ltd. CENTRAL INDEX KEY: 0001668243 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9 HA'TA'ASIYA ST CITY: RA'ANANA STATE: L3 ZIP: 4365007 BUSINESS PHONE: 972 9 770 7601 MAIL ADDRESS: STREET 1: 9 HA'TA'ASIYA ST CITY: RA'ANANA STATE: L3 ZIP: 4365007 4 1 rdgdoc.xml FORM 4 X0508 4 2023-08-31 0001668243 UroGen Pharma Ltd. URGN 0001821479 Smith Jason Drew 400 ALEXANDER PARK DRIVE PRINCETON NJ 08540 1 General Counsel 0 Ordinary Shares 2023-08-31 4 M 0 8334 A 22207 D Ordinary Shares 2023-08-31 4 S 0 3800 18.01 D 18407 D Restricted Stock Units 2023-08-31 4 M 0 8334 0 D Ordinary Shares 8334 0 D Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. The reporting person was granted RSUs on August 31, 2020 representing 25,000 ordinary shares. The RSUs vested in three equal installments on November 30, 2021, August 31, 2022 and August 31, 2023. /s/ Jason D. Smith, Attorney-in-Fact 2023-09-05